Drug establishmentActive, Registered FY2026FDA warning letter on file

Amneal Pharmaceuticals of New York, LLC

Amneal Pharmaceuticals of New York, LLC is an FDA-registered drug establishment (FEI 3005263655) located in , New York. The facility is active, registered for FY2026. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Aug 27, 2025
CGMP/Finished Pharmaceuticals/Adulterated

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Recalls (1)

Apr 15, 2020 Class II
CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

Recall data from openFDA enforcement reports (FDA Recall Enterprise System).

Establishment record

FEI Number
3005263655
Address
50 Horseblock Rd, , New York
Establishment type
Drug establishment
Products / operations
ANALYSIS; LABEL; MANUFACTURE; PACK; REPACK
Registration status
Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file
None on file
Form 483 observations
None on file

FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.

Questions

Is Amneal Pharmaceuticals of New York, LLC registered with the FDA?

Yes. Amneal Pharmaceuticals of New York, LLC is an FDA-registered drug establishment (FEI 3005263655) in , New York. Its current registration status is Active, Registered FY2026.

Has Amneal Pharmaceuticals of New York, LLC received an FDA warning letter?

Yes. FDA issued a warning letter to Amneal Pharmaceuticals of New York, LLC; the most recent is dated Aug 27, 2025 (CGMP/Finished Pharmaceuticals/Adulterated).

What does Amneal Pharmaceuticals of New York, LLC do?

Amneal Pharmaceuticals of New York, LLC's FDA-registered operations are: ANALYSIS; LABEL; MANUFACTURE; PACK; REPACK.

Related facilities

Source: FDA public data · status as of 2026-06-01

The Quality Brief

Every new FDA drug and device warning letter and recall, summarized once a week. Free.